American Heart Journal Plus: Cardiology Research and Practice
Scope & Guideline
Pioneering Insights in Heart Health
Introduction
Aims and Scopes
- Cardiovascular Disease Mechanisms and Treatment:
Research articles often explore the underlying mechanisms of cardiovascular diseases, including heart failure, arrhythmias, and coronary artery disease, alongside novel therapeutic approaches such as pharmacotherapy and interventional procedures. - Health Disparities and Social Determinants of Health:
A significant focus is placed on understanding and addressing health disparities, particularly within marginalized populations, emphasizing how social determinants influence cardiovascular outcomes. - Innovative Diagnostic and Therapeutic Technologies:
The journal highlights advancements in diagnostic technologies, such as imaging techniques and biomarker assessments, as well as new therapeutic modalities including catheter-based interventions and pharmacological treatments. - Cardio-Oncology and Cardiovascular Toxicity:
There is a growing emphasis on the intersection of cardiology and oncology, exploring the cardiovascular implications of cancer treatments and the management of patients with coexisting cardiovascular conditions. - Gender and Racial Disparities in Cardiovascular Health:
Research aims to elucidate the differences in cardiovascular health outcomes across genders and races, advocating for tailored prevention and treatment strategies.
Trending and Emerging
- Impact of COVID-19 on Cardiovascular Health:
Recent publications increasingly explore the cardiovascular implications of COVID-19, including its effects on patients with pre-existing conditions and the long-term outcomes post-infection. - Telemedicine and Remote Patient Monitoring:
With the rise of telehealth, there is growing research on the efficacy and outcomes of remote monitoring technologies for managing cardiovascular diseases, particularly in the context of the COVID-19 pandemic. - Interdisciplinary Approaches in Cardio-Oncology:
Emerging studies focus on the intersection of cardiology and oncology, highlighting how cancer treatments affect cardiovascular health and the importance of integrated care models. - Personalized Medicine and Pharmacogenomics:
There is an increasing emphasis on personalized treatment strategies based on genetic and phenotypic variations among patients, particularly in the context of pharmacotherapy for cardiovascular diseases. - Environmental and Lifestyle Factors in Cardiovascular Health:
Research is trending towards understanding the impact of environmental factors, such as pollution and lifestyle choices, on cardiovascular health, highlighting the role of public health initiatives.
Declining or Waning
- Traditional Risk Factor Studies:
There is a noticeable decrease in studies focusing solely on traditional cardiovascular risk factors (e.g., hypertension, hyperlipidemia) without incorporating newer insights into pathophysiological mechanisms or social determinants. - Basic Science Research:
The journal has seen a reduction in purely basic science studies that do not translate into clinical practices, as the emphasis shifts towards applied research with immediate clinical relevance. - Single-Center Studies:
There is a waning interest in single-center studies that do not contribute to broader, multi-institutional or population-based understanding of cardiovascular health, reflecting a trend towards larger cohort studies and multi-center trials. - Generalized Guidelines without Contextual Adaptation:
Research articles that merely reiterate existing clinical guidelines without contextual adaptation to specific populations or settings are becoming less common, as there is a push for more personalized medicine approaches.
Similar Journals
Nepalese Heart Journal
Empowering Heart Health Through Collaborative ResearchNepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.
Nature Reviews Cardiology
Unveiling Insights that Shape Cardiac CareNature Reviews Cardiology, published by NATURE PORTFOLIO, stands as a premier academic journal in the field of cardiology and cardiovascular medicine, boasting an impressive impact factor and a distinguished ranking of #1 out of 387 in Scopus. Since its inception in 2009, this exemplary journal has continuously delivered cutting-edge reviews and insights, supporting researchers, healthcare professionals, and students in navigating the complex landscape of cardiovascular health. With a commitment to providing open access and disseminating rigorous research, Nature Reviews Cardiology captures the forefront of innovation and scholarship, critical for facilitating advancements in cardiovascular science and clinical practice. Situated in the United Kingdom and with a vibrant global readership, this journal perpetuates academic excellence, ensuring accessibility to the latest findings that shape prevention, diagnosis, and treatment strategies in cardiology through to 2024 and beyond.
KARDIOLOGIYA
Elevating Insights in Cardiovascular MedicineKARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.
Indian Heart Journal
Innovating Solutions for Heart Health ChallengesIndian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.
CIRCULATION
Unveiling Breakthroughs in Cardiovascular Science.CIRCULATION is a premier journal in the field of cardiology and cardiovascular medicine, published by Lippincott Williams & Wilkins. With a distinguished history dating back to 1950, the journal has consistently been at the forefront of critical research, showcasing significant advancements and discoveries in cardiovascular health. It holds a remarkable Q1 ranking in both the fields of Cardiology and Physiology (medical) according to the 2023 category quartiles, demonstrating its influential role among the top publications in these disciplines. With an impressive Scopus ranking, placed 3rd out of 387 in Cardiology and 2nd out of 113 in Physiology, CIRCULATION is essential reading for researchers, practitioners, and students passionate about advancing their understanding of heart health and related medical sciences. Although the journal is not open access, it continues to foster scholarly exchange and innovation in cardiovascular research, making it an indispensable resource for quality insights and groundbreaking studies.
CANADIAN JOURNAL OF CARDIOLOGY
Empowering Cardiovascular Innovations Through Rigorous ResearchCanadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.
Kardiologia Polska
Innovative Research for a Healthier TomorrowKardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.
Netherlands Heart Journal
Transforming Cardiology Insights into Global Health SolutionsNetherlands Heart Journal is a premier academic publication dedicated to advancing knowledge in the field of cardiology and cardiovascular medicine. Published by BOHN STAFLEU VAN LOGHUM BV, this journal has established itself as a critical platform for researchers, professionals, and students seeking to explore groundbreaking findings and innovative practices in cardiovascular health. With an ISSN of 1568-5888 and E-ISSN 1876-6250, the journal boasts a respectable Q2 ranking in the Cardiology and Cardiovascular Medicine category, placing it in the top half of its field according to the 2023 quartiles. The Scopus ranking places it 130th out of 387 in the relevant category, indicating a commendable percentile rank of 66th, which attests to its influence and quality of published research. Spanning from 2005 to 2024, the journal endeavors to include a diverse array of topics, encompassing clinical practice, technological innovations, and public health considerations related to cardiovascular diseases. Researchers and practitioners are encouraged to engage with the journal's robust content, contributing to and benefiting from the collaborative effort to enhance cardiovascular health worldwide.
ACTA CARDIOLOGICA
Illuminating the path to better cardiovascular care.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
Journal of Cardiovascular Development and Disease
Connecting global scholars in the pursuit of cardiovascular excellence.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.